A new study found that younger postmenopausal women with normal bone density are at a very low risk of fractures. Without osteoporosis, it took an average of 11 years for just 1% to sustain a vertebral fracture and 3% to sustain a major osteoporotic fracture.
The North American Menopause Society (NAMS) has launched a free menopause mobile app, MenoPro, that uses an algorithm to help clinicians and patients make personalized treatment decisions. The app offers two modes, including one for healthcare providers and one for patients, and provides access to NAMS resources and a cardiovascular di...
The North American Menopause Society (NAMS) has published its first comprehensive set of evidence-based recommendations for the care of midlife women. The guide covers over 50 key topics, including vasomotor symptoms and osteoporosis, providing practical advice for clinicians and patients.
The new term GSM describes the complex genital, sexual, and urinary symptoms women experience after menopause. By standardizing a physical examination tool, healthcare providers can diagnose and treat these conditions more accurately and effectively.
A new study published in Menopause finds that lifelong soy consumption helps prevent atherosclerosis and improves cholesterol levels in premenopausal monkeys. After menopause, switching to a soy diet can also improve cholesterol levels, but has limited effect on plaque progression.
A recent study found that acupuncture can positively impact both the frequency and severity of hot flashes in women undergoing natural menopause. The analysis revealed that various forms of acupuncture, including traditional Chinese medicine and sham acupuncture, were effective in reducing hot flash frequency for up to three months.
A pilot study found a significant correlation between weight loss and reduced hot flashes in overweight or obese women. The study's findings suggest that behavioral weight loss may be an effective method for managing menopausal hot flashes, promoting healthy aging and overall well-being.
A nested case-control study found an association between older maternal age at birth of the last child and exceptional longevity. Women who had their last child beyond age 33 years had twice the odds for survival, with an increased risk tempered by having multiple children.
A new study published in Menopause found that calcium and vitamin D supplements can lead to high levels of calcium in the blood and urine in some older women. The risk was higher for those with lower initial calcium levels and increased age.
A recent study published in Menopause found that low doses of testosterone cream for women after menopause can bring their testosterone levels back to normal. The study tested two doses of the AndroFeme product, with the 5-mg dose being sufficient to restore premenopausal levels.
A new study found that PMS before menopause is linked to a poorer quality of life after menopause, particularly with depression, poor sleep, and memory problems.
A new study finds that women who experience early menopause at ages 40-45 are 40% more likely to develop heart failure than those who enter menopause between 50-54. Smoking also significantly increases the risk of heart failure in these women.
A new study from the Women's Health Initiative found no link between low vitamin D levels and menopause symptoms, including hot flashes, night sweats, and sleep disturbances. The study analyzed data from 530 women participating in the calcium and vitamin D WHI trial.
Taking care of grandkids one day a week may boost cognitive function, but excessive caregiving can have negative effects. A study of Australian grandmothers aged 57-68 found that social engagement and mental sharpness were linked.
A new study from the Women's Health Initiative found that calcium and vitamin D supplements can lower LDL cholesterol levels and raise HDL cholesterol in postmenopausal women. Vitamin D levels also played a significant role, with higher levels associated with improved cholesterol profiles.
A six-month pilot program called WAIPointes, funded by insurance, helped 83 women aged 35-55 achieve weight loss, lower blood pressure, and improved hot flash symptoms through lifestyle changes. The program's interactive approach and personalized support led to significant health risks reduction.
A new analysis of data from the Women's Interagency HIV Study reveals that anxiety is the biggest factor affecting thinking skills in midlife women with HIV. Mental processing speed and verbal memory were more closely linked to depression, anxiety, and hot flashes in both HIV-infected and healthy women.
A randomized, controlled trial shows that injecting anesthetic near a nerve bundle in the neck significantly reduces moderate to severe hot flashes in postmenopausal women. The treatment cut the number of hot flashes in half and reduced their intensity by 38% compared to a sham injection.
A study found that adding testosterone to hormone therapy did not significantly improve quality of life, self-esteem, or mood in women with primary ovarian insufficiency. Normalizing testosterone levels may not address underlying factors contributing to mood problems.
Two new studies published in Menopause journal show that low-dose flibanserin improves sexual function in postmenopausal women, while high-dose testosterone also yields benefits, but with cautionary notes on cardiovascular risks.
A new study found that hormone therapy has no significant impact on the quality of life for recently menopausal women without hot flashes. Women with moderate to severe hot flashes did experience improvements in sleep and other symptoms, but not overall health or sexual well-being.
A new study published in Menopause found that a specific bacterial mix may contribute to vaginal dryness and pain after menopause. The researchers suggest that personalized probiotics could prevent or treat vulvovaginal atrophy (VVA), a common cause of sexual pain, offering an alternative to traditional therapies.
The North American Menopause Society (NAMS) has published new guidance for diagnosing and treating vulvovaginal atrophy (VVA), a condition affecting up to 45% of women after menopause. The guidance emphasizes the importance of effective treatments, including simple vaginal lubricants, estrogen therapy, and nonhormonal options.
The North American Menopause Society (NAMS) has announced the recipients of its 2013 awards, honoring exceptional contributions to menopause research, practice, and education. This year's awards recognize outstanding clinicians, researchers, educators, and media professionals who have expanded knowledge about midlife women's health.
A 12-week aerobic exercise program showed no significant reduction in hot flashes among postmenopausal women. However, white women and those with initial fitness levels improved with exercise. Exercise had small positive effects on sleep quality, insomnia, and depression.
Women who survive cancer have more frequent, severe, and troubling hot flashes than other women with menopausal symptoms. However, the study also found that the cancer survivors reported better psychological and social well-being, similar levels of sexual activity and function compared to women without cancer.
A study published in Menopause found that women with HIV suffer from moderate to severe hot flashes, which significantly impact their daily functioning and overall well-being. The study also highlighted the potential risks of hot flashes on their health, HIV treatment, and ability to abstain from drugs and alcohol.
A large analysis of the Women's Health Initiative trial found that combining hormone therapy with calcium and vitamin D supplements significantly reduces the risk of hip fractures. The study suggests that women taking postmenopausal hormone therapy should consider taking these supplements to boost bone health.
A study of 1,500 women reveals that hot flashes and night sweats can occur before menopause, particularly among white women, Asian women, and those with certain dietary habits. The findings shed light on the complex factors influencing midlife symptoms and provide reassurance for women experiencing unexpected hot flashes.
A global survey found that treatment with vaginal estrogen improved sex lives for postmenopausal women, reducing pain and increasing satisfaction. The study also showed a positive impact on self-esteem and relationships.
Research confirms memory problems are a real symptom of menopause, exacerbated by hot flashes and negative emotions. Women experiencing more severe symptoms struggled with memory retention.
Researchers found a significant association between hypertensive diseases during pregnancy and vasomotor symptoms, including hot flashes and night sweats, in middle-aged women. The study of 853 women in the Netherlands suggests a potential biological link between these conditions and cardiovascular disease risk.
A study published in Menopause found that higher levels of routine daily physical activity, particularly household and caregiving chores, were associated with better sleep and fewer nighttime awakenings for women with hot flashes. The positive effects were mainly observed in white, non-obese women.
Researchers found that estrogen alone significantly reduced joint pain in women who had undergone a hysterectomy, with 74% of those taking estrogen experiencing no pain after three years compared to 80% of those taking a placebo. The Women's Health Initiative trial showed modest but significant differences between the two groups.
A study of 292 Brazilian women aged 45-72 found that daily step count is a strong predictor of health outcomes, with active women less likely to be obese or develop metabolic syndrome. The study supports the importance of incorporating physical activity into daily life for midlife women's overall health.
A recent study published in Menopause found that hypnosis can effectively manage hot flashes in postmenopausal women, leading to significant reductions in frequency and severity. The study showed a 57% reduction in skin conductance, which is a measure of hot flash symptoms.
A recent study published in Menopause found that about one-third of women who stopped taking the SSRI antidepressant escitalopram experienced a relapse of hot flashes and night sweats. Women with insomnia and those who responded less well to the medication were more likely to experience a relapse.
15 top medical organizations have issued a statement of agreement regarding the benefits of hormone therapy for symptomatic menopausal women. The statement concludes that hormone therapy is still an acceptable treatment for menopausal symptoms and has been endorsed by leading organizations in women's health.
The Women's Health Initiative has revealed that hormones produce a mix of risks and benefits for postmenopausal women. The trial found that HT varies with age, being safer when started soon after menopause.
The new report updates the landmark STRAW system, providing a clearer understanding of reproductive aging in women from pre-menopause to the late postmenopausal period. The updated stages include significant revisions, offering more precise definitions and predictions for the onset of menopause.